| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G | Report | May 29, 2024 | ||
| SC 13G | Report | May 29, 2024 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G/A | Report | Feb 13, 2024 | ||
| SC 13G | Report | Feb 9, 2024 | ||
| SC 13G | Report | Feb 7, 2024 | ||
| SC 13G/A | Report | AMENDMENT NO. 2 TO SCHEDULE 13G | Feb 6, 2024 | |
| SC 13G | Report | Jun 13, 2023 | ||
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | AMENDMENT NO. 1 | Feb 13, 2023 | |
| SC 13G | Report | (AMENDMENT NO. 1)* | Feb 13, 2023 | |
| SC 13G/A | Report | AMENDMENT NO. 1 TO SCHEDULE 13G | Feb 8, 2023 | |
| SC 13G | Report | Aug 5, 2022 | ||
| SC 13G | Report | SCHEDULE 13G | Aug 1, 2022 | |
| SC 13G | Report | SC 13G | Jul 28, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 15, 2022 | |
| SC 13G/A | Report | Feb 11, 2022 | ||
| SC 13G/A | Report | Jan 27, 2022 | ||
| SC 13G/A | Report | KIORA PHARMACEUTICALS, INC. | Jan 24, 2022 | |
| SC 13G | Report | Aug 20, 2021 | ||
| SC 13G | Report | EYEGATE PHARMACEUTICALS, INC. | Aug 20, 2021 | |
| SC 13G | Report | Aug 19, 2021 | ||
| SC 13G | Report | SCHEDULE 13G | Aug 18, 2021 | |
| SC 13G | Report | Aug 17, 2021 | ||
| SC 13G | Report | Aug 13, 2021 | ||
| SC 13G/A | Report | EYEG 13GA | Feb 9, 2021 | |
| SC 13G | Report | EYEG 13G | Feb 5, 2020 | |
| SC 13G/A | Report | SC 13G/A | Jan 27, 2020 | |
| SC 13G | Report | SC 13G | Nov 26, 2018 | |
| SC 13G | Report | SCHEDULE 13G | Apr 23, 2018 | |
| SC 13G/A | Report | Apr 18, 2018 | ||
| SC 13G/A | Report | Feb 14, 2018 | ||
| SC 13G/A | Report | EYEGATE PHARMACEUTICALS, INC. | Jan 16, 2018 | |
| SC 13G | Report | Jun 19, 2017 | ||
| SC 13G/A | Report | SC 13G/A | Jun 16, 2017 | |
| SC 13G | Report | EMPERY ASSET MANAGEMENT, LP | Jun 14, 2017 | |
| SC 13G/A | Report | AMENDMENT NO. 2 | Feb 14, 2017 | |
| SC 13G/A | Report | SC 13G/A | Feb 16, 2016 | |
| SC 13G | Report | SC 13G | Mar 4, 2015 |